Patents by Inventor Renuka Sivendran

Renuka Sivendran has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Stabilized Formulations Containing Anti-NGF Antibodies
    Publication number: 20210107974
    Abstract: The present invention provides pharmaceutical formulations comprising a human antibody that specifically binds to human nerve growth factor (hNGF). The formulations may contain, in addition to an anti-hNGF antibody, at least one non-ionic surfactant, at least one sugar, and acetate. The pharmaceutical formulations of the present invention exhibit a substantial degree of antibody stability after storage for several months.
    Type: Application
    Filed: December 7, 2020
    Publication date: April 15, 2021
    Applicant: Regeneron Pharmaceuticals, Inc.
    Inventors: Scott Walsh, Terra Potocky, Daniel Dix, Renuka Sivendran
  • STABILIZED FORMULATIONS CONTAINING ANTI-NGF ANTIBODIES
    Publication number: 20190010222
    Abstract: The present invention provides pharmaceutical formulations comprising a human antibody that specifically binds to human nerve growth factor (hNGF). The formulations may contain, in addition to an anti-hNGF antibody, at least one non-ionic surfactant, at least one sugar, and acetate. The pharmaceutical formulations of the present invention exhibit a substantial degree of antibody stability after storage for several months.
    Type: Application
    Filed: September 19, 2018
    Publication date: January 10, 2019
    Applicant: Regeneron Pharmaceuticals, Inc.
    Inventors: Scott Walsh, Terra Potocky, Daniel Dix, Renuka Sivendran
  • STABILIZED FORMULATIONS CONTAINING ANTI-NGF ANTIBODIES
    Publication number: 20160017029
    Abstract: The present invention provides pharmaceutical formulations comprising a human antibody that specifically binds to human nerve growth factor (hNGF). The formulations may contain, in addition to an anti-hNGF antibody, at least one non-ionic surfactant, at least one sugar, and acetate. The pharmaceutical formulations of the present invention exhibit a substantial degree of antibody stability after storage for several months.
    Type: Application
    Filed: October 5, 2015
    Publication date: January 21, 2016
    Inventors: Scott WALSH, Terra POTOCKY, Daniel DIX, Renuka SIVENDRAN
  • STABILIZED FORMULATIONS CONTAINING ANTI-NGF ANTIBODIES
    Publication number: 20120014968
    Abstract: The present invention provides pharmaceutical formulations comprising a human antibody that specifically binds to human nerve growth factor (hNGF). The formulations may contain, in addition to an anti-hNGF antibody, at least one non-ionic surfactant, at least one sugar, and acetate. The pharmaceutical formulations of the present invention exhibit a substantial degree of antibody stability after storage for several months.
    Type: Application
    Filed: July 11, 2011
    Publication date: January 19, 2012
    Applicant: Regeneron Pharmaceuticals, Inc.
    Inventors: Scott Walsh, Terra Potocky, Daniel Dix, Renuka Sivendran